FDA Investigator Nathaniel R Esaw
Nathaniel R Esaw has inspections in 2 countries as of 16 Dec 2022. Nathaniel R Esaw has collaborated with a combined 1594 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
16 Dec 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada
Co-Investigator(s):
Amanda M Osteen,
Amos C Epps,
Amy M Cramer,
Arindam Dasgupta, PhD,
Brandon L Mariner,
Brian P Hendrickson,
Brian R Yaun,
Brooke K Higgins,
Brooke K Seeman,
Bruce C Kovak,
Candice C Mandera,
Candice C Mandero,
Candice J Cortes,
Carol Mrivera Lopez, PhD,
Carol Rivera Lopez, PhD,
Carrie L Doupnik,
Charlean R Butler,
Cynthia A Harris, MD, RN,
Dennis L Doupnik,
Dianne H Milazzo,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Edward P Potter,
Elise A Murphy,
Emmanuel A Dimaano, Jr,
Erin L Mcfiren,
Esaw,
Frank J Marciniak,
Gale L Glinecki,
Gerald D Bromley, Jr,
Gifford Whitehurst, Jr,
Gopa Bisivas,
Harperd,
Heath A Gerber,
Huixia Zhang,
Jackie O'shaughnessy,
Jacqueline A O'shanghnessy, PhD,
Jacqueline A O'shaughnessy, PhD,
Jacqueline N O'shaughnessy,
James M Simpson,
Jamie D Richardson,
Jaqueline A O'shaughnessy,
Jesse P Hardin,
Jessica D Weber,
Joey C West,
John A Kadavil, PhD,
John M Gusto,
Johnson,
Jose R Hernandez,
Jude C Dikes,
Julie A Silberberg,
Justin A Hefferman,
Laiza V Garcia,
LCDR Wilfred A Darang,
Lisa B Orr,
Lori S Lawless,
Marc S Neubauer,
Marcus A Ray,
Martin K Yau, PhD,
Mathew R Manen,
Matthew R Mcnew,
Michael D Ellison,
Michael F Skelly, PhD,
Sam H Haidar, PhD,
Samuel H Chan, PharmD,
Sean Y Kassim, PhD,
Sherry I Seerist,
Sherry L Secrist, BLT DO,
Sierra M Shockley,
Srinivas R Chennamaneni, PhD,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Stephen C Eason,
Steven J Thurber,
Tamal K Chakraborti, PhD,
Tiki J Dixon,
William A Warnick,
William D Tingley,
William H Linkroum,
William L Bargo,
Xikui Chen (nmi), PhD,
Yih Chain Huang, PhD
Nathaniel R Esaw's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2009 | EIR | Buitoni Food Company - EIR, 2009-03-12 |
May, 2000 | EIR | PARI Respiratory Equipment, Inc. - EIR, 2000-05-03 |
May, 2000 | FDA 483 | PARI Respiratory Equipment, Inc. - Form 483, 2000-05-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more